- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02815852
RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLD (RAD2016)
February 7, 2024 updated by: Azienda U.S.L. 1 di Massa e Carrara
The purpose of this study is to review retrospectively cases of breast cancer of the centers belonging to the BREST UNIT Tuscany North-West Wide Area and compare the imaging characteristics (ultrasound, mammography and mammary MRI if available) of breast cancer with the corresponding histological reports and assess whether in women <40 years the typical imaging presentation pattern of malignancies observed in women> 40 years are confirmed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Breast cancer is the most frequent cancer in women and the leading cause of death in women under 50 years in the USA.
In Italy, the Pool Airtum 2007-2010 figures confirm that breast cancer, excluding skin cancers, is 29% of cancers diagnosed in women and the leading cause of death in women, for the regions in which are active the cancer registries .
Among women, breast cancer ranks first in all age groups: represents 29% of deaths in women aged <49 years, 23% in women between 50 and 69 years and 16% between women aged> 70 years.
The disease is uncommon before age 30 but the European Cancer registries have detected since 1990 an increased incidence of breast cancer in women before age 40.
For this reason it can be important to start to verify the incidence of breast cancer before age 40 in the BREAST UNIT of the Tuscany North-West Wide Area (Versilia, Lucca and Massa-Carrara).
Mammography, which is the reference examination for prevention in women after age 40, has not shown before this age evidence of efficacy.
Ultrasound examination, complementary to mammography, is generally well tolerated but did not demonstrate efficacy in prospective studies as a screening in reducing mortality.
MRI with intravenous contrast medium is considered the exam with higher sensitivity in identifying neoplastic lesions especially in young women.
This study therefore aims to review retrospectively cases of breast cancer of the centers belonging to the BREST UNIT Tuscany North-West Wide Area to locate a number of cases to allow for a comparison on the imaging characteristics (ultrasound, mammography and mammary MRI if available) of breast cancer and assess whether in women <40 years the typical imaging presentation pattern of malignancies observed in women> 40 years are confirmed.
In this study will be involved pathological anatomy of the BREAST UNIT Tuscany North-West Wide Area (Massa-Carrara, Versilia, Lucca); Radiology (Massa-Carrara, Versilia, Lucca); Clinical breast surgery / oncology / radiology of the three USL (Massa-Carrara, Versilia, Lucca) of the Tuscany North-West Wide Area.
Data of patients diagnosed with breast cancer from 01/01/2009 to 31/12/2015 will be collected starting in july 2016 and the publication of results will take place by December 2016.Risk factors, genetic mutations, receptors status, tumor stage, therapies for NHL / LH and previous breast tumors will be analyzed as well.
The data will be stratified by: age (<30 years, 30-35 years and 35-39 years), biological parameters on histology, stage at diagnosis and imaging features.
Patients undergoing breast biopsy sampling represent an already select group who may be susceptible to information bias inherent risk factors: to reduce this bias will recover all the information about the risk factors for breast cancer.
2) operator-dependent variability of ultrasound images: will be taken into account in the data analysis, as well as different machines used in the various hospitals and diversity of the reporting method.
3) The patients for which it will not be possible to correct analysis of the data will be excluded, but the selection bias of patients will still be taken into account in the analysis of the data.The statistical analysis will be done in 1 month, and the results will be published by December 2016.
Study Type
Observational
Enrollment (Actual)
210
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 39 years (Child, Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Women aged <40 years with breast cancer diagnosis from 01/01/2009 to 31/12/2015 by imaging guided biopsy and / or histology of the surgical specimen extracted from the database of pathological anatomy afferent BREAST UNIT of Tuscany North-West Wide Area.
Description
Inclusion Criteria:
- Women aged <40 years with breast cancer diagnosis from 01/01/2009 to 31/12/2015 by imaging guided biopsy and / or histology of the surgical specimen extracted from the database of pathological anatomy afferent BREAST UNIT of Tuscany North-West Wide Area.
Exclusion Criteria:
- Women aged > 40 years with breast cancer diagnosis from 01/01/2009 to 31/12/2015 by imaging guided biopsy and / or histology of the surgical specimen extracted from the database of pathological anatomy afferent BREAST UNIT of Tuscany North-West Wide Area.
- Women aged <40 years with breast cancer diagnosis before 01/01/2009 of after 31/12/2015 by imaging guided biopsy and / or histology of the surgical specimen extracted from the database of pathological anatomy afferent BREAST UNIT of Tuscany North-West Wide Area.
- Patients with ultrasound examination and risk factors not available
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare the imaging features of benign and malignant mammary lesions in women <40 years with histological examinations to assess the correlatability between imaging morphology and histological characteristic of breast lesions.
Time Frame: September 2016
|
It will be made a comparison between the radiological and histological reports of all patients with breast cancer diagnosis.
|
September 2016
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluate the incidence of malignant breast disease on total access to the Breast Unit of the Tuscany North-West Wide Area in patients <40 years
Time Frame: September 2016
|
September 2016
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
June 24, 2016
First Submitted That Met QC Criteria
June 27, 2016
First Posted (Estimated)
June 28, 2016
Study Record Updates
Last Update Posted (Actual)
February 8, 2024
Last Update Submitted That Met QC Criteria
February 7, 2024
Last Verified
December 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Az.USLToscana Nord Ovest
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer in Women Under 40 Years Old
-
Karabuk UniversityBolu Izzet Baysal Physiotherapy and Rehabilitation Training and Research...CompletedBeing Between 40-80 Years Old | Being Diagnosed With Haemiplegia | Getting 20 Points or More in the Mini Mental Test | Volunteering to Participate in the Study | Level 2 or Above According to Functional Ambulation ClassificationTurkey
-
Poitiers University HospitalActive, not recruitingSurgery | Female Breast Cancer | 75 Years Old and MoreFrance
-
University of MichiganMichigan Department of Community HealthCompletedBreast Cancer | Breast Cancer in Young Women | Breast Cancer in Women With a Strong Family HistoryUnited States
-
UNICANCERGlaxoSmithKlineCompletedMetastatic Breast Cancer | 70 Years Old Patients and Over | After One Line of Chemotherapy With TrastuzumabFrance
-
Federal University of MaranhaoNot yet recruitingBreast Cancer | Breasts - Female | Breast Cancer in Women
-
HJ23Joan XXIII University HospitalCompletedColorectal Cancer | Colorectal Cancer in Patients Under 50 Years of AgeSpain
-
Novartis PharmaceuticalsTerminatedPrimary Hormone Receptor Negative Breast Cancer in Premenopausal WomenGermany
-
Novartis PharmaceuticalsUniversity of Sheffield; Danish Breast Cancer Cooperative GroupCompletedHormone Sensitive Resected Primary Breast Cancer in Postmenopausal WomenDenmark, United Kingdom
-
Marmara UniversityNot yet recruitingBreast Cancer Awareness and BSE in Visually Impaired WomenTurkey
-
Karolinska InstitutetCompletedWomen With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2Sweden
Clinical Trials on Women under 40 years old with histological diagnosis of breast cancer
-
Institut Cancerologie de l'OuestCompleted
-
Instituto de Investigación Hospital Universitario...CompletedBreast Neoplasm Female | Cancer, Breast | Nutrition Related Cancer | Habits, DietSpain
-
French Cardiology SocietyAstraZeneca; Daiichi Sankyo, Inc.; Boston Scientific Corporation; Abbott Medical... and other collaboratorsCompletedAcute Myocardial Infarction | Women Over 18 and Under 50 Years of AgeFrance
-
Cheng-Hsin General HospitalRecruitingBreast NeoplasmsTaiwan
-
Instituto Jalisciense de CancerologiaUniversity of GuadalajaraUnknownObesity | Breast Cancer | Nutrition Disorders | Vitamin D Deficiency | Endocrine Therapy | Endocrine Therapy Adverse ReactionMexico
-
Meng QiuActive, not recruiting
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)Completed
-
National Cancer Institute (NCI)WithdrawnT Acute Lymphoblastic Leukemia | T Lymphoblastic Lymphoma
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Lymphoblastic Lymphoma | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, New Zealand, Australia